Real-time enrollment status for this non-hodgkin lymphoma clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:13 AM UTC
| NCT Number | NCT06149286 |
| Recruiting Status | Recruiting |
| Condition | Non-Hodgkin Lymphoma |
| Phase | Clinical Trial |
| Target Enrollment | 470 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | February 5, 2026 (3 weeks ago) |
As of March 2, 2026: Clinical trial NCT06149286 is currently recruiting participants. This clinical trial study for non-hodgkin lymphoma is actively seeking new participants at 7 locations across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06149286 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06149286 was last updated 3 weeks ago (February 5, 2026). HelloStudys verifies this status automatically.